Nancy D. Bone

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

Neil E. Kay, Susan M. Geyer, Timothy G. Call et al. · Blood · 2006 · 293 citations · Full text

Pharmacy, Immunology, Oncology +14

Chromosome anomalies detected by interphase fluorescence <i>in situ</i> hybridization: correlation with significant biological features of B‐cell chronic lymphocytic leukaemia

Gordon W. Dewald, Stephanie R. Brockman, Sarah F. Paternoster et al. · British Journal of Haematology · 2003 · 216 citations

Life Sciences, Hematology, Molecular Biology +17

VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia

Yean Kee Lee, Nancy D. Bone, Ann K. Strege et al. · Blood · 2004 · 209 citations

Life Sciences, Cell Biology, Pharmacology +16

Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis

Priyabrata Mukherjee, Resham Bhattacharya, Nancy D. Bone et al. · Journal of Nanobiotechnology · 2007 · 207 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

Analysis of clonal B‐cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B‐chronic lymphocytic leukaemia

Diane F. Jelinek, Renee C. Tschumper, Susan M. Geyer et al. · British Journal of Haematology · 2001 · 203 citations

Medicine, Immunology, Oncology +14